Based on the previous finding of TOX expression concurrent with that of PD-1 and Tim-3 in T cells from patients with lymphoma (21), we analyzed the correlation of the gene expression level of the TOX genes and IC genes in AML patients (Figures 5A–C). This evidence concerns the gene HAVCR2 and lymphoma.